From: The Japanese Clinical Practice Guideline for acute kidney injury 2016
Bodyweight (kg) | 0~ | 1 | 2 | 3 | Â | 5 | Â | 10 | Â | 15 | 20 | 25 | |
Filter surface area (m2) | Â | Â | 0.03 | Â | Â | Â | Â | 0.3 | Â | 0.7 | Â | Â | |
Priming | Packed red blood cells ± albumin (A) | A | A | A | A | A | A | A/B | C | C | C | C | C |
Albumin (B) | |||||||||||||
Saline (C) | |||||||||||||
Catheter size | 18G | 17G | Â | 6Fr | Â | 7Fr | Â | 8Fr | Â | 9Fr | 10Fr | 11Fr | |
QB | 1~5 (mL/min) × bodyweight |  |  |  | 3~15 |  |  |  | 10~50 |  |  |  |  |
QD | QB × (0.2~2.0) |  |  |  | 36~1800 |  |  |  | 120~6000 |  |  |  |  |
QF | QB × (0~0.2) |  |  |  | 0~180 |  |  |  | 0~600 |  |  |  |  |
Anticoagulation | Nafamostat mesilate | Â | Â | Â | 1.5~3Â mg/h | Â | Â | Â | 5~10Â mg/h | Â | Â | Â | Â |
Heparin | Â | Â | Â | 30~60 unit/h | Â | Â | Â | 100~200 unit/h | Â | Â | Â | Â |